These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2669186)

  • 21. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized comparison of maintenance treatment with androgens, immunotherapy, and chemotherapy in adult acute myelogenous leukemia. A Leukemia-Lymphoma Group Trial of the EORTC.
    Hayat M; Jehn U; Willemze R; Haanen C; Zittoun R; Monconduit M; Lowenberg B; Stryckmans P; Peetermans M; De Cataldo F
    Cancer; 1986 Aug; 58(3):617-23. PubMed ID: 3524789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica.
    Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G
    Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maintenance therapy in childhood acute myeloid leukemia.
    Perel Y; Auvrignon A; Leblanc T; Michel G; Vannier JP; Dalle JH; Gandemer V; Schmitt C; Mèchinaud F; Lamagnere JP; Piguet Ch; Couillaud G; Pautard B; Baruchel A; Leverger G; ;
    Ann Hematol; 2004; 83 Suppl 1():S116-9. PubMed ID: 15124700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 27. DNA as a carrier for anthracyclines in the treatment of acute myelocytic leukemia (AML).
    Gahrton G; Tidefelt U; Paul C; Björkholm M; Grimfors G; Hast R; Juliusson G; Järnmark M; Killander A; Kimby E
    Leukemia; 1992; 6 Suppl 2():89-91. PubMed ID: 1578953
    [No Abstract]   [Full Text] [Related]  

  • 28. Late intensification with POMP chemotherapy prolongs survival in acute myelogenous leukemia--results of a Southwest Oncology Group study of rubidazone versus adriamycin for remission induction, prophylactic intrathecal therapy, late intensification, and levamisole maintenance.
    Morrison FS; Kopecky KJ; Head DR; Athens JW; Balcerzak SP; Gumbart C; Dabich L; Costanzi JJ; Coltman CA; Saiki JH
    Leukemia; 1992 Jul; 6(7):708-14. PubMed ID: 1625490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic results in acute myelogenous leukemia in the years from 1970 to 1982].
    Kurrle E; Hoelzer D; Heimpel H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(5):698-709. PubMed ID: 2416646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intensive sequential chemotherapy for children with acute myelogenous leukemia: VAPA, 80-035, and HI-C-Daze.
    Grier HE; Gelber RD; Link MP; Camitta BP; Clavell LA; Weistein HJ
    Leukemia; 1992; 6 Suppl 2():48-51. PubMed ID: 1374493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapy of adult acute nonlymphoblastic leukaemia.
    Jacobs P; Martell RW; Wilson EL
    Haematologia (Budap); 1990; 23(1):27-40. PubMed ID: 2204594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reinduction therapy for adult acute leukemia with adriamycin, vincristine, and prednisone: a Southwest Oncology Group study.
    Elias L; Shaw MT; Raab SO
    Cancer Treat Rep; 1979 Aug; 63(8):1413-5. PubMed ID: 289442
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of 100 acute myeloid leukemias (author's transl)].
    Fière D; Martin C; Vu Van H; Coiffier B; Felman P; Bryon PA; Favre-Gilly J; Revol L
    Sem Hop; 1979 Apr 8-15; 55(13-14):633-8. PubMed ID: 224478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute non-lymphoblastic leukemia in children: prognostic factors and results of chemotherapy.
    Advani SH; Charak BS; Banavali SD; Gopal R; Nair CN; Saikia TK; Pai SK; Kurkure PA; Nadkarni KS; Pai VR
    Indian Pediatr; 1990 Jan; 27(1):14-20. PubMed ID: 2361737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TAD-induction therapy for 175 adults with acute myeloid leukemia, followed by consolidation and maintenance therapy. The joint study of Ulm and Tübingen.
    Link H; Kurrle E; Frauer HM; Heil G; Heimpel H; Waller HD; Ostendorf P; Wilms K; Hoelzer D
    Onkologie; 1986 Jun; 9(3):135-8. PubMed ID: 3528958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy realization and complications in the BFM-83 therapy study of acute myelogenous leukemia].
    Creutzig U; Hofmann J; Ritter J; Schellong G
    Klin Padiatr; 1988; 200(3):190-9. PubMed ID: 3062255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress and survival factors in acute non lymphocytic leukemia. A 15 year analysis.
    Friedman S; Cowan DH; Nabholtz JM; Pinkerton PH; Senn JS
    Nouv Rev Fr Hematol (1978); 1992; 34(3):233-7. PubMed ID: 1408734
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intensification of chemotherapy of acute myeloid leukemia in children: report on the studies of the AML-BFM 78 and AML-BFM 83 protocols].
    Creutzig U; Ritter I; Schellong G
    Gematol Transfuziol; 1991 Jan; 36(1):16-21. PubMed ID: 2065939
    [No Abstract]   [Full Text] [Related]  

  • 39. [Late results of the treatment of acute granulocytic leukemia in adults].
    Perilov AA; Volkova MA; Frenkel' MA
    Ter Arkh; 1989; 61(7):8-11. PubMed ID: 2588148
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
    Steinherz PG; Gaynon P; Miller DR; Reaman G; Bleyer A; Finklestein J; Evans RG; Meyers P; Steinherz LJ; Sather H
    J Clin Oncol; 1986 May; 4(5):744-52. PubMed ID: 3517244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.